CIPLA Cipla Ltd Other Situations Announcement 2025 - USFDA Approval Cipla Ltd received USFDA approval on April 10, 2025, for its injectable cancer treatment, Protein-bound Paclitaxel, expected to launch in H1 FY 2025-26..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Cipla Ltd